Lenz, H., Chen, E. X., Han, S., Tie, J., Cercek, A., Muro, K., Kawazoe, A., Modest, D. P., Folprecht, G., Cremolini, C., Siena, S., André, T., Elez, E., García-Alfonso, P., Moniz, C. M. V., Shiu, K., Khakoo, S., Manzella, G., Henry, C., Ducreux, M. P. (2026). A phase 1b/2, multicenter, open-label study to evaluate the efficacy and safety of GSK5764227 (GSK’227), alone and in combination in patients with previously treated advanced unresectable or metastatic gastrointestinal solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.tps264